Development of engineered cells for implantation in gene therapy

Ross, 1996, Gene therapy in the United States: a five year status report, Hum. Gene Ther., 7, 1781, 10.1089/hum.1996.7.14-1781 Blau, 1995, Gene therapy – A novel form of drug delivery, N. Engl. J. Med., 333, 1204, 10.1056/NEJM199511023331808 P.L. Chang, Nonautologous somatic gene therapy, in: P.L. Chang (Ed.), Somatic Gene Therapy, CRC Press, Boca Raton, FL, 1995, pp. 203–223. Stockley, 1997, Nonautologous somatic gene therapy: a novel approach to drug delivery, Drug News Perspect., 10, 331 J.M. Rappeport, Indications and applications of bone marrow transplantation, in: R. Hoffman, E.J. Benz Jr., S.J. Shattil, B. Furie, H.J. Cohen (Eds.), Hematology: Basic Principles and Practice, Churchill Livingstone, New York, NY, 1991, pp. 230–242. Kohn, 1995, Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency, Nat. Med., 1, 1017, 10.1038/nm1095-1017 Blaese, 1995, T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years, Science, 270, 475, 10.1126/science.270.5235.475 Bordignon, 1995, Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients, Science, 270, 470, 10.1126/science.270.5235.470 Seldon, 1987, Implantation of genetically engineered fibroblasts into mice: implications for gene therapy, Science, 236, 714, 10.1126/science.3472348 Chang, 1990, Autologous fibroblast implantation: feasibility and potential problems in gene replacement therapy, Mol. Biol. Med., 7, 461 Seppen, 1997, Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation, Hum. Gene Ther., 8, 27, 10.1089/hum.1997.8.1-27 Grossman, 1994, Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia, Nat. Genet., 6, 335, 10.1038/ng0494-335 Snyder, 1997, Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors, Nat. Genet., 16, 270, 10.1038/ng0797-270 Choate, 1996, Corrective gene transfer in the human skin disorder lamellar ichthyosis, Nat. Med., 2, 1263, 10.1038/nm1196-1263 Fenjves, 1994, Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy, Hum. Gene Ther., 5, 1241, 10.1089/hum.1994.5.10-1241 Gerrard, 1993, Towards gene therapy for haemophilia B using primary human keratinocytes, Nat. Genet., 3, 180, 10.1038/ng0293-180 Barr, 1991, Systemic delivery of recombinant proteins by genetically modified myoblasts, Science, 254, 1507, 10.1126/science.1962212 Yao, 1992, Expression of human factor IX in mice after injection of genetically modified myoblasts, Proc. Natl. Acad. Sci. USA, 89, 3357, 10.1073/pnas.89.8.3357 Naffakh, 1996, Long-term secretion of therapeutic proteins from genetically modified skeletal muscles, Hum. Gene Ther., 7, 11, 10.1089/hum.1996.7.1-11 Shull, 1996, Myoblast gene therapy in canine mucopolysaccharidosis I: abrogation by an immune response to L-iduronidase, Hum. Gene Ther., 7, 1595, 10.1089/hum.1996.7.13-1595 Herzog, 1997, Stable gene transfer and expression of human blood coagulation factor IX after intramusclular injection of recombinant adeno-associated virus, Proc. Natl. Acad. Sci. USA, 94, 5804, 10.1073/pnas.94.11.5804 Elder, 1996, Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer, Hum. Gene Ther., 7, 479, 10.1089/hum.1996.7.4-479 Tahara, 1995, IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts, Hum. Gene Ther., 6, 1607, 10.1089/hum.1995.6.12-1607 Crystal, 1995, Transfer of genes to humans: early lessons and obstacles to success, Science, 270, 404, 10.1126/science.270.5235.404 Ishibashi, 1993, Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery, J. Clin. Invest., 92, 883, 10.1172/JCI116663 Kozarksy, 1994, In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses, J. Biol. Chem., 269, 13695, 10.1016/S0021-9258(17)36886-2 Bennett, 1996, Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy, Nat. Med., 2, 649, 10.1038/nm0696-649 Zabner, 1993, Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis, Cell, 75, 207, 10.1016/0092-8674(93)80063-K Crystal, 1994, Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis, Nat. Genet., 8, 42, 10.1038/ng0994-42 Knowles, 1995, A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patient with cystic fibrosis, N. Engl. J. Med., 333, 823, 10.1056/NEJM199509283331302 Wolff, 1990, Direct gene transfer into mouse muscle in vivo, Science, 247, 1465, 10.1126/science.1690918 Jiao, 1992, Direct gene transfer into nonhuman primate myofibres in vivo, Hum. Gene Ther., 3, 21, 10.1089/hum.1992.3.1-21 Davis, 1993, Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle, Hum. Gene Ther., 4, 733, 10.1089/hum.1993.4.6-733 Wu, 1989, Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo, J. Biol. Chem., 264, 16985, 10.1016/S0021-9258(18)71447-6 Tsukamoto, 1995, Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice, Nat. Genet., 9, 243, 10.1038/ng0395-243 Caplan, 1995, Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Nat. Med., 1, 39, 10.1038/nm0195-39 Cao, 1995, Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA–lipofectin complex, Hum. Gene Ther., 6, 1497, 10.1089/hum.1995.6.11-1497 Nabel, 1994, Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma, Hum. Gene Ther., 5, 1089, 10.1089/hum.1994.5.9-1089 Kaneda, 1989, Increased expression of DNA cointroduced with nuclear protein in adult rat liver, Science, 243, 375, 10.1126/science.2911748 Curiel, 1991, Adenovirus enhancement of transferrin-polylysine mediated gene delivery, Proc. Natl. Acad. Sci. USA, 88, 8850, 10.1073/pnas.88.19.8850 Cotten, 1992, High-efficiency receptor-mediated delivery of small and large (48 kb) gene constructs using the endosome-disruption activity of defective or chemically-inactivated adenovirus particles, Proc. Natl. Acad. Sci. USA, 89, 6094, 10.1073/pnas.89.13.6094 Cristiano, 1993, Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes, Proc. Natl. Acad. Sci. USA, 90, 2122, 10.1073/pnas.90.6.2122 Wagner, 1992, Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes, Proc. Natl. Acad. Sci. USA, 89, 6099, 10.1073/pnas.89.13.6099 Wilson, 1992, Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein-deficient rabbits, J. Biol. Chem., 267, 963, 10.1016/S0021-9258(18)48379-2 Poncet, 1996, Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo, Gene Ther., 3, 731 Sun, 1998, Microencapsulation of pancreatic islet cells: a bioartificial endocrine pancreas, Methods Enzymol., 137, 575, 10.1016/0076-6879(88)37053-9 Awrey, 1996, Permeability of alginate microcapsules to secretory recombinant gene products, Biotechnol. Bioeng., 52, 472, 10.1002/(SICI)1097-0290(19961120)52:4<472::AID-BIT3>3.0.CO;2-M King, 1987, Alginate–polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering, Biotechnol. Prog., 3, 231, 10.1002/btpr.5420030407 O'Shea, 1984, Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane, Biochim. Biophys. Acta, 804, 133, 10.1016/0167-4889(84)90107-1 Wong, 1991, A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival, Biomater. Artif. Cells Immobilization Biotechnol., 19, 687, 10.3109/10731199109117847 Tse, 1996, Secretion of recombinant proteins from hydroxyethyl methacrylate–methyl methacrylate capsules, Biotechnol. Bioeng., 51, 271, 10.1002/(SICI)1097-0290(19960805)51:3<271::AID-BIT3>3.0.CO;2-A Chang, 1993, Delivery of recombinant gene products with microencapsulated cells in vivo, Hum. Gene Ther., 4, 433, 10.1089/hum.1993.4.4-433 C.J.D. Ross, P.L. Chang, Microencapsulation – A novel gene therapy for lysosomal storage diseases, in: W.M. Kuhtreiber, R.P. Lonza, W.L. Chick (Eds.), Handbook of Encapsulated Cell Technology and Therapeutics, Birkhauser, Boston, 1997, chapt. 28. Sassoon, 1993, Myogenic regulatory factors: dissecting their role and regulation during vertebrate embryogenesis, Dev. Biol., 156, 11, 10.1006/dbio.1993.1055 Olson, 1992, Interplay between proliferation and differentiation within the myogenic lineage, Dev. Biol., 154, 261, 10.1016/0012-1606(92)90066-P Crescenzi, 1994, Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells, J. Cell Biol., 125, 1137, 10.1083/jcb.125.5.1137 Nguyen, 1983, Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment, Cell, 34, 281, 10.1016/0092-8674(83)90159-9 K.M. Bowie, P.L. Chang, Differentiation of recombinant myoblasts in alginate microcapsules (in preparation). Devlin, 1983, Re-entry into the cell cycle of differentiated skeletal myocytes, Dev. Biol., 95, 175, 10.1016/0012-1606(83)90016-7 Chamberlain, 1985, Regulation of creatine kinase induction in differentiating mouse myoblasts, Mol. Cell. Biol., 5, 484, 10.1128/MCB.5.3.484 Shainberg, 1971, Alterations of enzymatic activities during muscle differentiation in vitro, Dev. Biol., 25, 1, 10.1016/0012-1606(71)90017-0 Miller, 1992, Myoblast diversity in skeletal myogenesis: how much and to what end?, Cell, 69, 1, 10.1016/0092-8674(92)90111-O Ludolph, 1995, Transcription factor families: muscling in on the myogenic program, FASEB J., 9, 1595, 10.1096/fasebj.9.15.8529839 Blau, 1993, Myoblasts in pattern formation and gene therapy, Trends Genet., 9, 269, 10.1016/0168-9525(93)90012-7 Mangan, 1996, A muscle-specific variant of microtubule-associated protein 4 (MAP4) is required in myogenesis, Development, 122, 771, 10.1242/dev.122.3.771 Seigneurin-Venin, 1996, Involvement of the dihydropyridine receptor and internal Ca2+ stores in myoblast fusion, Exp. Cell Res., 223, 301, 10.1006/excr.1996.0085 Peck, 1993, Differential effects of over-expressed neural cell adhesion molecule isoforms on myoblast fusion, J. Cell Biol., 123, 1587, 10.1083/jcb.123.6.1587 Zeschnigk, 1995, Involvement of M-cadherin in terminal differentiation of skeletal muscle cells, J. Cell Sci., 108, 2973, 10.1242/jcs.108.9.2973 Fazeli, 1996, Altered secondary myogenesis in transgenic animals expressing the neural cell adhesion molecule under the control of a skeletal muscle-actin promoter, J. Cell Biol., 135, 241, 10.1083/jcb.135.1.241 Hortelano, 1996, Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of Hemophilia B, Blood, 87, 5095, 10.1182/blood.V87.12.5095.bloodjournal87125095 Lin, 1992, Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth, Nature, 360, 767, 10.1038/360765a0 Al-Hendy, 1995, Allogeneic somatic gene therapy: correction of growth hormone deficiency in mice with microencapsulated non-autologous myoblasts, Hum. Gene Ther., 6, 165, 10.1089/hum.1995.6.2-165